Stocktoria
Theravance Biopharma, Inc. TBPH
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-05-16
Theravance Biopharma, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | 2026-06-19 | Grant | 18,750 | — |
| Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 2026-06-15 | Sell | 3,329 | $16.39 |
| Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 2026-06-15 | Sell | 3,328 | $16.38 |
| Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 2026-06-15 | Sell | 6,657 | $16.39 |
| Smaldone Alsup Laurie | director | 2026-06-12 | Grant | 6,009 | — |
| GRAY SUSANNAH | director | 2026-06-12 | Grant | 6,009 | — |
| MITCHELL DEAN J | director | 2026-06-12 | Grant | 6,009 | — |
| O'Connor Donal | director | 2026-06-12 | Grant | 6,009 | — |
Source: SEC EDGAR filings · CIK 0001583107 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.